Detection of a strain of Enterobacter cloacae co-carrying NDM-1 and KPC-2 genes and its drug resistance
10.3760/cma.j.issn.1674-2397.2017.02.009
- VernacularTitle:同时携带blaNDM-1和blaKPC-2基因的一株阴沟肠杆菌检测及临床治疗分析
- Author:
Xiaojie ZHAO
;
Fei JIANG
;
Haiquan KANG
;
Lihua DENG
;
Bing GU
;
Ping MA
- Keywords:
Enterobacter cloacae;
Microbial sensitivity tests;
Plasmid;
KPC-2;
NDM-1;
Clinical treatment
- From:
Chinese Journal of Clinical Infectious Diseases
2017;10(2):130-134
- CountryChina
- Language:Chinese
-
Abstract:
Objective To identify the drug resistance-related genes in a clinically isolated strain of Enterobacter cloacae.Methods A strain of Enterobacter cloacae was isolated from sputum of a patient with chronic obstructive pulmonary disease from the Affiliated Hospital of Xuzhou Medical University in March 2013.Modified Hodge test and metal enzyme inhibition test were performed for drug-resistant phenotype screening.Carbapenemase genes blaMUS-1, blaVIM-1, blaVIM-2, blaIMP, blaKPC-2, blaNDM-1, blaOXA-48 and blaGESwere amplified by polymerase chain reaction (PCR), and the positive products were sequenced and analyzed.Plasmid conjugation and transformation experiments were used to confirm that the resistance gene mediated by plasmids.Agar dilution method was used for antibiotic susceptibility test.Results Both modified Hodge test and metal enzyme inhibition test were positive in this strain of Enterobacter cloacae.blaNDM-1 gene and blaKPC-2 gene were detected by PCR, and further confirmed by sequencing.blaNDM-1 gene was carried by IncX plasmid with 54×103 bp, KPC-2 gene was carried by untyping plasmid with 42×103 bp.The strain was only sensitive to tetracycline (MIC=2 μg/mL) and tigecycline (MIC=1 μg/mL).The symptoms were improved after the patient was treated by tigecycline combined with Piperacillin/Tazobactam.Conclusion blaNDM-1 and blaKPC-2 genes in Enterobacter cloacae can be mediated by plasmids, and appropriate therapy for its infection should be based on the result of antibiotic susceptibility test.
